BI Biotech India a major distributor of biological research
reagents for the lifescience industry, has clocked a revenue of `31.11 crores for the last fiscal year.

The company has earned creditability and has established itself into the lifescience research market, with its
key focus onto provide customers value added services which makes it a preferred vendor. With substantial
increase in revenue every year, the company has maintained its growth consistently. During the year, it has introduced cost effective DuoSet -5 plates (R&D Systems), molecular range of products in its portfolio from TIANGEN Biotech. The company has decided to absorb the shipping charges.

The company represents some of the US based world renowned Canada, Major Science, Taiwan, IKA, Germany.
As per company, a comprehensive range of products under its product portfolio, helps it to meet the
requirements of scientists. The company believes that their customer service boosted its growth. The
firm aims to provide cutting edge technologies from across the globe through strategic global partnerships
with giant firms like R&D systems, Tochris Biosciences, Boston Biochemand many others.

In the long run, BI Biotech plans to extend sales network by enhancing services and establishing itself as an
important source for not only its key products but also for newly developed product alternatives. Moving ahead, the firm aims to achieve revenues of set `34.32 crores for the next fiscal year.